Devazepide

Devazepide

SCHEMBL8613468

CN1C(=O)[C@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c2ccccc2)c2ccccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 16/20 1.00
CCKAR P32238 13/20 1.00
ADRB2 P07550 1/20 1.00
TSPO P30536 1/20 1.00
GLP1R P43220 1/20 1.00
FFAR4 Q5NUL3 1/20 1.00
PDE4A P27815 2/20 0.64
PDE4B Q07343 2/20 0.64
PDE4C Q08493 2/20 0.64
PDE4D Q08499 2/20 0.64
PDE5A O76074 1/20 0.64
PDE1A P54750 1/20 0.64
PDE1B Q01064 1/20 0.64
PDE1C Q14123 1/20 0.64
GABRP O00591 1/20 0.62
GABRD O14764 1/20 0.62
GABRA1 P14867 1/20 0.62
GABRB1 P18505 1/20 0.62
GABRG2 P18507 1/20 0.62
GABRB3 P28472 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Devazepide SCHEMBL4884074 1.00 CCKBR (1.00) CCKBRCCKARADRB2TSPOGLP1R
Devazepide SCHEMBL6255769 1.00 CCKBR (1.00) CCKBRCCKARADRB2TSPOGLP1R
Devazepide SCHEMBL29406251 1.00 CCKBR (1.00) CCKBRCCKARADRB2TSPOGLP1R
Devazepide SCHEMBL148766 1.00 CCKBR (1.00) CCKBRCCKARADRB2TSPOGLP1R
Devazepide SCHEMBL31616311 1.00 CCKBR (1.00) CCKBRCCKARADRB2TSPOGLP1R
SCHEMBL8437864 0.94 CCKBR (0.88) CCKBRCCKARADRB2TSPOGLP1R
SCHEMBL9842437 0.94 CCKBR (0.88) CCKBRCCKARADRB2TSPOGLP1R
SCHEMBL9422963 0.91 CCKBR (0.83) CCKBRCCKARADRB2TSPOGLP1R
SCHEMBL7143510 0.90 CCKBR (0.82) CCKBRCCKARADRB2TSPOGLP1R
SCHEMBL7143513 0.90 CCKBR (0.82) CCKBRCCKARADRB2TSPOGLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5817658-A ADMINISTERING A DIAZEPINE COMPOUND; DISEASES OF THE EAR MERCK & COMPANY, INC. (US) 1998-10-06 US disclosed
US-5776930-A CARDIOVASCULAR DISORDERS MERCK & COMPANY, INC. (US) 1998-07-07 US disclosed
US-5597818-A CARDIOVASCULAR DISORDERS MERCK & CO., INC. (US) 1997-01-28 US disclosed
US-5595990-A TREATMENT OF CARDIOVASCULAR DISORDERS MERCK & CO., INC. (US) 1997-01-21 US disclosed
EP-0445976-B1 Gamma emitting, CCK-A antagonists for pancreatic imaging MERCK & CO INC (US) 1996-05-01 EP disclosed
US-5428031-A Benzodiazepine analogs; cardiovascular disorders MERCK & CO., INC. (US) 1995-06-27 US disclosed
US-5426185-A Antiarrhythmia agents having reduced side effects MERCK & CO., INC. (US) 1995-06-20 US disclosed
WO-1995014471-A1 ANTIARRHYTHMIC BENZODIAZEPINES MERCK & CO., INC. (US) 1995-06-01 WO disclosed
EP-0445976-A1 Gamma emitting, CCK-A antagonists for pancreatic imaging MERCK & CO. INC. (US) 1991-09-11 EP disclosed
US-4994258-A Radiolabeled cholecystokinin-A antagonists bind to receptors MERCK & CO., INC. (US) 1991-02-19 US disclosed